Easy access to a self-assembled glycolipid derived from bhilawanol: a promising anti-cancer drug
In this study, we synthesised a series of self-assembling glycoconjugates derived from bhilawanol under environmentally friendly conditions in good yields. These self-assembling glycoconjugates displayed anti-cancer activity toward HeLa cells at an IC<sub>50</sub> value of 125 μM with minimal side effects, holding immense potential in cancer therapeutics.
Authors
- Kajal Sandhu
- Subbiah Nagarajan (ORCID: https://orcid.org/0000-0003-2233-4872)
- Tohira Banoo
- S Chockalingam
Institutions
- National Institute of Technology Warangal (IN)
Publication Details
- Journal
- Chemical Communications
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5cc01621e
- Citations
- 1
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- National Institute of Technology Warangal
- Department of Science and Technology, Ministry of Science and Technology, India
- Science and Engineering Research Board